non invasive glucose monitor
No more blood to measure your glucose
Pain free and strip free
Produced in England
Long term the most economical solution on the market
the egm1000 is produced by Evia Medical Technologies Ltd, United Kingdom.
the egm1000 is distributed in Nigeria by Kainico. firstname.lastname@example.org
European Union authorisation n. 3901411CE01
Nigeria NAFDAC authorisation n. 03-6594
For Diabetics type 2 and pre-diabetics, above 16 years.Measures the tissue glucose.Is calibrated to the user once, when starting to use a new ear-clip. Price includes calibration at a nearby clinic/endocronologist.
Now available in Nigeria.
The egm1000 measures your diabetes in three ways
Each technology measures different tissue parameters that are affected by the same change in glucose concentration, but is confined by the impact of interfering factors, due to lack of specificity. Therefore, a simultaneous evaluation of the above mentioned physiological changes through measurement of different sets of tissue perturbations, induced by changes in glucose concentration, increases the validity of the end result. The three independent readings are combined together by a proprietary algorithm, which calculates their weighted average.
(phase shift as a function of speed of sound change within the tissue) – An ultrasonic wave travels from a transmitter, placed on one side of the earlobe, through the earlobe tissue and received at the other side. Zips et al  showed that the sound velocity depends linearly on the glucose concentration in a water-glucose solution. They also described sound velocity dependency on temperature. Moreover, the temperature dependence is more significant than that of the glucose concentration. One should note that these dependencies are not opposite to each other, meaning in the hyperglycemic range, the temperature increases as well as the concentration and thus the velocity of sound is expected to increase significantly. Furthermore, in live tissues, the influence of glucose concentration on the velocity of sound is more profound than the demonstration in Zips and associates’ study. This is since glucose-induced water transport affects tissue density as well as compressibility and they also affect the sound velocity .
(conductivity of the tissue) – The device has two parallel foils, which act like capacitor’s plates. Thus the earlobe utilizes as a dielectric material between the two capacitor plates. Voltage application between the two plates stimulates the earlobe tissue, current measurement allows for impedance assessment. This method is plausible as a glucose assessment technique since plasma glucose induces ion shift across the cellular membrane in red blood cells and as a result changes membrane potential . Furthermore, Hayashi et al  demonstrated that variations of the metabolically active enantiomer d-glucose affect the permittivity and conductivity of the cellular membranes. Tissue impedance is changed due to changes in blood glucose concentration and is therefore monitored .
(heat capacity of the tissue) – A known (controlled) amount of energy is applied to the earlobe using a heat source for a predetermined period of time. The temperature developed on the earlobe as a result of the heating is glucose dependent, according to the bio-heat transfer equation, which describes the thermal properties changes of a living tissue .
The egm1000 is a certified medical device. A decade was spent on developing the technology
and perfecting it to reach the accuracy required for approval by the different countries Ministries of Health.
Sticking your finger to draw your blood is free, but the strips that you use cost in Nigeria around USD 60cents each.
Your Endocronologist has probably asked you to measure after each meal, so 3 times per day. In 10 years this
comes to USD 6 570 in strips plus the cost of the device around USD 40.
The egm1000 is available for around USD 2300 calibration included. The earpiece is replaced every 6 months.
So for the same 10 years, the egm1000 will require 19 ear pieces * USD 150 per ear piece = 2850. Grand total
is USD 5 150.
The economics becomes better the longer you use it. And because diabetes is a lifelong disease, regretfully,
you are likely required to measure your glucose for many more years.
The real benefit however is difficult to measure in price. Because of the discomfort of drawing blood, many diabetics that
are relying on strips, are over time likely to measure their glucose less and less. The reduced measuring increases the
chance of us diabetics straying away from the lifestyle we need to live. The consequences may not be easy to see in the
beginning, but once the symptoms start, can be dramatic.
The story behind
The desire to develop a non-invasive glucose monitor came from one of the Evia founders, the late Dr. David Freger. David had diabetes and like many who suffer from this life-long debilitating disease, David was sick and tired of pricking his fingers to draw blood several times each day. Together with two of his trusted colleagues, they set out to develop a non-invasive glucose monitor that could provide pain-free measurements.
Following years of intense research and development they determined that the technical challenges of increasing the signal to noise ratio, to obtain a reliable reading without drawing blood, could best be achieved by combining three independent technologies simultaneously. They developed a proprietary and patented approach of using ultrasound, electromagnetic and thermal measurements with a unique algorithm to weigh each measurement and calculate the weighted average of the three readings. The development took a decade.
The device measures tissue/skin glucose and not blood glucose. So it is an indirect measurement. The glucose in the blood can be detected from the tissue/skin after some minutes.
There is a lot of noise inside the body that contributes to inaccuracy. It’s therefore hard to distinguish the glucose signal noninvasively from other parameters inside the body and from external factors such as temperature. So Evia decided to work with three technologies that reduce the noise rather than increase the signal as other technologies attempts to do.
The device was tested on more than 800 people prior to commercialization. It is intended for indoor use because readings are affected by wind and temperatures, needs to be within a range of 15 to 35 degrees Celsius. The device informs the user if he/she is outside temperature limits.
This innovative approach was recognized by Frost & Sullivan, who awarded the company a Product Innovation Leadership award. Frost & Sullivan is based in USA with 40 offices worldwide. They issue industry awards based on research.
David Freger passed away from diabetes complications at the age 48 in 2004. His colleagues completed the research and then the device. The egm1000 is a legacy that Dr David Freger left behind, to help persons with type2 diabetics. Today the egm1000 is sold in many countries and now also finally in Nigeria.
Frequently Asked Questions
- Is egm1000 more or less accurate than finger pricking ?
In a laboratory setting the finger pricking devises available in the market today are as accurate as the egm1000. However in the day-to-day situation of most users, surveys show that the egm1000 is far more accurate. This is because many users rarely follow the strict guidelines for fingerpricking, the two most important being to wipe the finger clean and not to take the first drop of blood but the second drop of blood.
- Why does the egm1000 have to be calibrated ?
Because the measurements depend on the physiology of each person.
- We bought our egm1000 in another country, can you calibrate it ?
Yes ofcourse, we would be happy to.
- What is the difference between the readings of tissue glucose compared to blood glucose ?
Usually 15-20 minutes from the levels seen in blood glucose (finger pricking), you should see the comparable level in tissue glucose (egm1000).
- Do you deliver and calibrate ?
Yes we deliver and calibrate in Lagos and in Abuja.
- I have diabetes type 2
The egm1000 was made for you
- I have diabetes type 1
The egm1000 is not for you unfortunately. Because Diabetes type 1 is a completely different disease compared to type 2.
insulin temperature shield
Protects your insulin from exceeding 29 degree celsius, the temperature where the insulin deteriorates.
Just switch it on and it works.
No need for refrigeration to activate.
Temperature Assurance Indicator.
Small and lightweight.
Good for one year of daily use.
Did you know that Insulin deteriorates when exposed to warm weather ?
If you depend on insulin, keep your insulin with you. With this high-end device
manufactured in England, have confidence that your insulin remains potent, whether
you are at home close to your fridge, or whether you are far away, either on a plane
or stuck in traffic.
EviaCool is a reusable temperature shield for insulin pens
EviaCool is intended to keep insulin cool within safe temperatures below 29°C (84.2°F)
for a minimum of 12 hours even in a constant environmental temperature of 37.8°C (100°F), when the device is placed inside a personal handbag. The cap temperature regulation is passive and combines thermal insulation with heat absorbent material.
The cap is reactivated/filled up to provide safe storage conditions, whenever
the ambient temperature gets below 26°C (78.8°F), for subsequent periods of 12 hours
and for up to 365 days (one year).
The insulin must always be at the manufacturer’s recommended temperature
Please refer to the insulin package insert of your specific insulin pen. The EviaCool
fits most insulin pens sold in Nigeria.
To fully appreciate the importance of keeping your insulin within the recommended
temperature, please ask your Endocronologist.